Strength Seen in Fulgent Genetics (FLGT): Stock Soars 11.6%
Fulgent Genetics, Inc. FLGT was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.83 –$50.51 in the past one-month time frame, witnessed a sharp increase yesterday.
This move came after the company announced that it will provide COVID-19 testing kits to students as they return to school from this month.
The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Fulgent Genetics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
FULGENT GENETIC Price
FULGENT GENETIC price | FULGENT GENETIC Quote
Fulgent Genetics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked stock in the Medical Info Systems industry is NextGen Healthcare, Inc. NXGN, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
FULGENT GENETIC (FLGT) : Free Stock Analysis Report
NEXTGEN HEALTHCARE, INC (NXGN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
